← Research index  ·  Disorder page  ·  Source YAML

Cross-provider research synthesis

Arterial Dissection Lentiginosis Syndrome

MONDO:0010889 Curated 2026-07-04T00:00:00Z 10 harmonized findings
falcon · 16 citations openscientist · 34 citations
Concordant asserts the finding Partial supports a weaker/qualified form Contradictory conflicts with it Silent does not address it

Harmonized findings

Arterial dissection-lentiginosis syndrome is an ultra-rare familial Mendelian arteriopathy defined by the co-occurrence of early-onset (often recurrent) arterial dissections, arterial-wall cystic medial necrosis/degeneration, and multiple cutaneous lentigines.

UNANIMOUS INTEGRATED
ProviderStanceScoreEvidence
falcon CONCORDANT 95% Arterial Dissections with Lentiginosis (ADL) is a very rare, primarily case-report–defined Mendelian syndrome characterized by early-onset, sometimes recurrent, dissections of large/medium arteries together with multiple cutaneous lentigines and arterial wall pathology consistent with cystic medial degeneration/necrosis.
Falcon states the defining triad (dissections of large/medium arteries, lentigines, cystic medial degeneration/necrosis) as a rare case-report-defined Mendelian syndrome.
DOI:10.1056/NEJM199503023320905
openscientist CONCORDANT 95% Arterial dissection-lentiginosis syndrome is an ultra-rare autosomal recessive Mendelian disorder characterized by the co-occurrence of spontaneous arterial dissection with underlying cystic medial necrosis and multiple lentigines (pigmented skin macules).
OpenScientist gives the same defining triad and adds the ultra-rare and autosomal recessive framing.
PMID:7838191

The leading developmental hypothesis is a neurocristopathy: because both melanocytes and the arterial tunica media of the aortic arch and its branches derive from neural crest cells, a neural-crest defect can explain the shared pigmentary and vascular phenotype.

UNANIMOUS INTEGRATED
ProviderStanceScoreEvidence
falcon CONCORDANT 90% A proposed etiology is a defect in neural-crest–derived lineages (“neurocristopathy”), because melanocytes derive from trunk neural crest and the tunica media of the aortic arch/branches derives from cranial neural crest
Falcon articulates the neurocristopathy hypothesis linking melanocytes and the arterial media through shared neural-crest origin.
openscientist CONCORDANT 90% the aortic valvular cusps and the arterial media of the aortic arch and its branches are derived from neural crest cells, suggesting that a neural crest defect may be the underlying abnormality in these families
OpenScientist quotes the same Schievink/Mokri neural-crest-defect rationale.
PMID:7570751

No causal gene or pathogenic variant has been identified for the syndrome; it remains genetically unresolved.

UNANIMOUS INTEGRATED
ProviderStanceScoreEvidence
falcon CONCORDANT 90% No ADL-specific pathogenic variant(s) were reported in the retrieved texts.
Falcon confirms no causal gene or variant in the retrieved ADL literature.
openscientist CONCORDANT 90% The HPO annotations, OMIM entry (600459), Orphanet, ClinVar, and Monarch Initiative databases all show zero confirmed gene associations.
OpenScientist agrees that no gene association is confirmed across the authoritative databases, despite proposing candidate genes.

The arterial-wall lesion is cystic medial necrosis — loss of smooth muscle cells and elastic fibers from the tunica media that weakens the wall and predisposes to dissection.

UNANIMOUS INTEGRATED
ProviderStanceScoreEvidence
falcon CONCORDANT 85% acute medial dissection with focal cystic degeneration of the media
Falcon reports the original resected-artery histopathology of medial dissection with focal cystic degeneration of the media.
openscientist CONCORDANT 90% Arterial wall: Cystic medial necrosis — loss of elastic fibers and smooth muscle cells
OpenScientist describes cystic medial necrosis as loss of elastic fibers and smooth muscle cells.

Inheritance is most consistent with autosomal recessive, but the original kindreds could not exclude autosomal dominant transmission with variable penetrance and expression.

MAJORITY INTEGRATED
ProviderStanceScoreEvidence
falcon PARTIAL 60% Reviews maintain that inheritance is “not clear,” noting the suggestion of autosomal recessive inheritance.
Falcon stresses the residual uncertainty — autosomal recessive is only suggested and dominant inheritance is not excluded — so it supports a weaker/qualified form of the claim.
openscientist CONCORDANT 85% the syndrome follows an autosomal recessive inheritance pattern (HP:0000007) as recorded in OMIM (600459)
OpenScientist asserts autosomal recessive inheritance flatly, citing OMIM, without emphasizing the dominant-not-excluded caveat.

The endothelin signaling pathway (EDN1, EDN3, EDNRB, EDNRA, ECE1) is proposed as the top candidate mechanism via a neural-crest "lineage-balance" model, where a partial mutation biases progenitors toward melanocyte fate (lentigines) at the expense of vascular smooth muscle (cystic medial necrosis).

SINGLE LEAD
ProviderStanceScoreEvidence
openscientist CONCORDANT 90% Endothelin signaling (EDN1, EDN3, EDNRB, EDNRA, ECE1) — supported by six convergent evidence lines (see Section 6).
OpenScientist proposes the endothelin pathway as the strongest candidate mechanism backed by six convergent evidence lines and a lineage-balance model.
PMID:28753427, PMID:15070746
falcon SILENT
Falcon's retrieval never invokes the endothelin pathway; it keeps to the generic neural-crest hypothesis and does not name endothelin genes.

The syndrome is extraordinarily rare, documented essentially in only two families/sibling pairs, with a handful of additional sporadic cases noted in later reviews; no prevalence or penetrance estimates exist.

MAJORITY INTEGRATED
ProviderStanceScoreEvidence
falcon CONCORDANT 85% No reliable penetrance/frequency estimates exist due to very small case counts; reviews cite two sibling pairs and six sporadic cases.
Falcon gives the case-count basis (two sibling pairs plus six sporadic cases) and the absence of penetrance/frequency estimates.
openscientist PARTIAL 70% Only 2 families (approximately <20 individuals)
OpenScientist agrees on the two-family core and ultra-rarity but does not mention the additional sporadic cases that Falcon's reviews cite — a minor coverage divergence, not a contradiction.

Lentigines characteristically appear in childhood, whereas arterial dissections present later, in adolescence or young adulthood (roughly the 2nd-4th decade).

UNANIMOUS INTEGRATED
ProviderStanceScoreEvidence
falcon CONCORDANT 85% lentigines in childhood; dissections in adolescence/young adulthood in reported kindreds
Falcon states the two-phase temporal pattern (childhood lentigines, later dissections) directly.
openscientist CONCORDANT 80% Young adulthood (typically 2nd–4th decade)
OpenScientist dates arterial dissection onset to young adulthood (2nd-4th decade) and elsewhere places lentigines in congenital/early childhood.

No syndrome-specific therapy is established; management follows general arterial-dissection principles (antithrombotic therapy, imaging surveillance), with endothelin receptor antagonists raised only as a speculative targeted option contingent on confirming the endothelin hypothesis.

MAJORITY LEAD
ProviderStanceScoreEvidence
falcon PARTIAL 50% No ADL-specific interventional or pharmacologic regimen is established in the retrieved literature.
Falcon confirms there is no ADL-specific regimen but does not elaborate the general management or any targeted option.
openscientist CONCORDANT 70% If endothelin pathway involvement confirmed, endothelin receptor antagonists (bosentan, macitentan) could be investigated.
OpenScientist details general antithrombotic management and adds the speculative endothelin receptor antagonist option tied to its mechanistic hypothesis.
PMID:20495147, PMID:26679613

The differential distinguishes the syndrome from other lentiginosis and arteriopathy disorders (Carney complex, LEOPARD/NSML, vascular Ehlers-Danlos) by its autosomal recessive pattern, hyperpigmentation, mucosal sparing, and dissection with cystic medial necrosis as the primary vascular feature.

UNANIMOUS LEAD
ProviderStanceScoreEvidence
falcon CONCORDANT 80% includes lentigines and congenital heart disease; NEJM authors note that spontaneous arterial dissections had not been noted in LEOPARD and other lentiginosis syndromes in their discussion, and their cases lacked other LEOPARD components
Falcon works through the LEOPARD/lentiginosis differential, noting arterial dissection had not been described in those syndromes.
openscientist CONCORDANT 85% Autosomal recessive (most differentials are AD); hyperpigmentation (not depigmentation); arterial dissection + cystic medial necrosis as primary vascular feature; absence of skeletal, cardiac, GI, or endocrine manifestations.
OpenScientist tabulates the distinguishing features against the full differential set (vascular EDS, Loeys-Dietz, Marfan, NSML, Carney, ABCD).

Narrative

Overview

Both providers frame arterial dissection-lentiginosis syndrome as an ultra-rare, case-report-defined familial Mendelian arteriopathy characterized by early arterial dissection, cystic medial necrosis of the arterial wall, and multiple cutaneous lentigines, with an unresolved causal gene and a neural-crest (neurocristopathy) developmental hypothesis as the unifying mechanism.

Agreement

The providers converge on the defining triad (arterial dissection, cystic medial necrosis, lentigines), the neurocristopathy hypothesis linking melanocytes and the neural-crest-derived arterial media, the absence of an identified causal gene or pathogenic variant, the extreme rarity (two families), the childhood onset of lentigines versus later dissection, and the differential diagnosis against other lentiginosis/arteriopathy syndromes.

Divergence

Falcon stays close to the original Schievink 1995 report and reviews, stressing inheritance uncertainty (autosomal recessive suggested but dominant not excluded) and offering no molecular candidate. OpenScientist goes further, asserting autosomal recessive inheritance from OMIM/Orphanet and building a detailed endothelin-pathway "lineage-balance" model (EDN1/EDN3/EDNRB/EDNRA/ECE1) from GWAS, developmental biology, GTEx co-expression, and mouse Ednrb data, plus a general antithrombotic management scheme and a speculative endothelin receptor antagonist option. On epidemiology they differ only mildly: Falcon adds six sporadic cases from reviews that OpenScientist omits. No direct contradictions were found between the two reports.

Integration

Promoted into kb/disorders/Arterial_Dissection_Lentiginosis_Syndrome.yaml: the conservative disease identity and defining triad, the neural-crest/mesenchymal developmental mechanism, cystic medial necrosis as the arterial-wall lesion, the unknown-causal-gene status, the childhood-lentigines/adult-dissection temporal pattern, the ultra-rare two-family epidemiology, and an inheritance entry that captures the provider disagreement (autosomal recessive suggested, dominant not excluded) rather than over-asserting.

Not integrated (leads)

The endothelin-pathway lineage-balance hypothesis, the detailed differential diagnosis, and the broad arterial-dissection management/targeted-therapy literature were retained as research leads rather than curated ADL-specific mechanism or treatment assertions, because they are extrapolated from related pigmentation and vascular systems and not confirmed for this syndrome.

Cross-provider synthesis comparing the falcon (original-report/review-focused) and openscientist (autonomous, endothelin-hypothesis-generating) deep-research reports for arterial dissection-lentiginosis syndrome. best_matching_text values are verbatim excerpts from the two report files; no direct contradictions were found — divergence is coverage/interpretation (inheritance certainty, the endothelin candidate mechanism, sporadic-case counts, and management detail). Literature evidence: blocks and ontology terms are intentionally left to the main curation pipeline on the disorder YAML.